Why BGPT?
logo

Design on What Was Actually Done

See the experiments, methods, and limitations behind existing claims before planning your next study.Know what the science actually supports before you trust the answer.

Press Enter ↡ to plan experiment



    Explore by Goal












     Quick Explanation


    Design overview for measuring ER Ca2+ in GMC101 (C. elegans)
    Key numeric readouts reported in the GMC101 + sca-1 (SERCA) RNAi study are shown below β€” all claims are taken directly from the paper.
    • sca-1 (SERCA) mRNA knockdown: 50% (reported)
    • Thioflavin-T aggregate area reduction: 32% (reported)
    • ER Ca2+ was not directly measured in the paper β€” authors used cytosolic YC2.1 FRET imaging and infer ER Ca2+ depletion as a likely mechanism (limitation noted)



     Long Explanation


    Visual experimental design + quantitative summary for ER Ca2+ measurements in GMC101

    Below are compact, directly-labelled visuals you can use to design and interpret experiments that measure ER Ca2+ (or infer ER Ca2+ changes) in the GMC101 AΞ²1-42 C. elegans model, grounded in the available data and limitations reported by the source paper.

    Figure: Direct numeric values reported by the study (see citation). These are the only quantitative ER-related numbers available in the paper; ER lumenal [Ca2+] itself was not directly measured by the authors and remains an experimental gap to be addressed when designing ER Ca2+ assays in GMC101.
    Figure: Hierarchy of assays to detect ER Ca2+ changes. Highest-specificity approaches measure ER lumen directly (e.g., ER-targeted genetically encoded Ca2+ indicators). The paper used cytosolic YC2.1 FRET β€” informative for downstream effects but insufficient to directly quantify ER lumen Ca2+ (authors note this limitation).
    Figure: Timeline schematic: study synchronizes worms, applies RNAi feeding (HT115 sca-1 or L4440 control), uses temperature upshift to 25Β°C to induce AΞ² toxicity, then assays paralysis at days 4 and 8 alongside imaging/biochemistry. This timeline is drawn from the methods summary in the paper; exact lengths of RNAi exposure and imaging timepoints are described there.

    Concrete design recommendations to measure ER Ca2+ in GMC101

    1. Directly measure ER lumen Ca2+ using an ER-targeted genetically encoded Ca2+ indicator (GECI) β€” e.g., D1ER, ER-GCaMP6-150 or CEPIA variants with an ER signal peptide + KDEL retention β€” expressed in body-wall muscle or pharyngeal muscle; this directly addresses the key limitation of the paper, which used cytosolic YC2.1 only .
    2. Co-express or co-image an ER-targeted Ca2+ sensor and cytosolic YC2.1 to correlate ER and cytosolic dynamics in the same animal; include sca-1 RNAi (100% and 10% dosing used in study) and L4440 controls to reproduce the reported dose-dependence.
    3. Use ratiometric or FRET GECIs and calibrate in vivo (ionomycin + EGTA/ high Ca2+ buffers) when possible to estimate lumenal [Ca2+] (quantitative calibration needed for cross-condition comparisons).
    4. Image at body-wall muscle and pharyngeal muscle regions used in the paper (they reported tissue-specific mitochondrial and functional changes) and collect spontaneous transients and evoked responses (e.g., optogenetic activation or pharmacological tracers) to distinguish basal load from release kinetics.
    5. Combine imaging with functional assays: paralysis scoring, mobility tracking, ThT aggregate imaging, and Seahorse OCR to connect ER Ca2+ states to physiological outcomes β€” these were the assays used in the paper to link sca-1 knockdown to phenotype.
    6. Run appropriate sample sizes: paralysis assays used ~300 worms per condition over 3 biological replicates in the study; plan imaging replicates per-animal and per-tissue accordingly to reach statistical power.

    Primary citation & critical limitations

    All recommendations above are motivated by the paper's findings and its explicitly stated limitations: sca-1 RNAi produced ~50% mRNA knockdown and a 32% reduction in ThT-positive aggregate area, cytosolic Ca2+ transients were recorded with YC2.1, but ER lumenal [Ca2+] was not directly measured β€” so experiments that directly target ER Ca2+ are the natural next step to falsify or confirm the inferred mechanism

    Note: the study provides strong functional links between partial SERCA loss and reduced AΞ² toxicity in GMC101 but does not directly measure ER lumen [Ca2+] β€” implementing ER-targeted GECIs with careful calibration is the most direct experiment to test the authors' mechanistic inference and either falsify or support their model.



    Feedback:    

    Updated: March 17, 2026

     Analysis Wizard



    Generating per-animal ROI extraction and time-series Ξ”F/F0 quantification for ER-GECI + YC2.1 movies and producing statistical summary tables (calibrated FRET ratios and event kinetics).



     Hypothesis Graveyard


    SERCA knockdown worsens AΞ² toxicity β€” contradicted by the reported improvements (reduced paralysis, aggregation reduction), so this is not supported by the data.


    All phenotypes are off-target RNAi artifacts β€” possible but less likely given dose-dependence and multiple functional readouts; requires rigorous controls to falsify.

     Science Art


    Design Experiments: ER Ca2 Measurements in GMC101 Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending